[{"address1": "419 Davis Drive", "address2": "Suite 100", "city": "Morrisville", "state": "NC", "zip": "27560", "country": "United States", "phone": "919 328 4400", "fax": "919 328 4402", "website": "https://www.liquidia.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.", "fullTimeEmployees": 145, "companyOfficers": [{"maxAge": 1, "name": "Dr. Roger A. Jeffs Ph.D.", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 1323080, "exercisedValue": 0, "unexercisedValue": 9949710}, {"maxAge": 1, "name": "Mr. Michael  Kaseta", "age": 47, "title": "COO & CFO", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 890805, "exercisedValue": 0, "unexercisedValue": 2625995}, {"maxAge": 1, "name": "Mr. Russell  Schundler", "age": 48, "title": "General Counsel & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 778486, "exercisedValue": 0, "unexercisedValue": 2151683}, {"maxAge": 1, "name": "Mr. William R. Kenan Jr.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ginger  Denison", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Krepp SPHR", "title": "Vice President of People & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason  Adair", "age": 51, "title": "Chief Business Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Moomaw", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajeev  Saggar M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Hunter", "title": "Senior Vice President of Manufacturing Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 6, "overallRisk": 10, "governanceEpochDate": 1726617600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.91, "open": 10.1, "dayLow": 9.91, "dayHigh": 10.475, "regularMarketPreviousClose": 9.91, "regularMarketOpen": 10.1, "regularMarketDayLow": 9.91, "regularMarketDayHigh": 10.475, "beta": 0.222, "forwardPE": -6.1130958, "volume": 1045212, "regularMarketVolume": 1045212, "averageVolume": 1246411, "averageVolume10days": 1112000, "averageDailyVolume10Day": 1112000, "bid": 10.25, "ask": 10.3, "bidSize": 400, "askSize": 1000, "marketCap": 866562112, "fiftyTwoWeekLow": 5.71, "fiftyTwoWeekHigh": 16.99, "priceToSalesTrailing12Months": 58.393673, "fiftyDayAverage": 10.8586, "twoHundredDayAverage": 12.41075, "currency": "USD", "enterpriseValue": 744447232, "floatShares": 48493682, "sharesOutstanding": 84378000, "sharesShort": 12255298, "sharesShortPriorMonth": 12873698, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.1596, "heldPercentInsiders": 0.19500999, "heldPercentInstitutions": 0.56672, "shortRatio": 7.27, "shortPercentOfFloat": 0.2599, "impliedSharesOutstanding": 84378000, "bookValue": 0.821, "priceToBook": 12.509136, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -112110000, "trailingEps": -1.58, "forwardEps": -1.68, "pegRatio": 0.05, "enterpriseToRevenue": 50.165, "enterpriseToEbitda": -7.768, "52WeekChange": 0.6071987, "SandP52WeekChange": 0.32258344, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LQDA", "underlyingSymbol": "LQDA", "shortName": "Liquidia Corporation", "longName": "Liquidia Corporation", "firstTradeDateEpochUtc": 1532611800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4e9d716d-8a04-3fbc-8a5a-0151bfd0dd75", "messageBoardId": "finmb_22761611", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.27, "targetHighPrice": 29.0, "targetLowPrice": 17.0, "targetMeanPrice": 24.0, "targetMedianPrice": 25.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 133093000, "totalCashPerShare": 1.733, "ebitda": -95836000, "totalDebt": 88869000, "quickRatio": 5.629, "currentRatio": 6.08, "totalRevenue": 14840000, "debtToEquity": 141.687, "revenuePerShare": 0.21, "returnOnAssets": -0.40693, "returnOnEquity": -1.81733, "freeCashflow": -70245504, "operatingCashflow": -75070000, "revenueGrowth": -0.235, "grossMargins": 0.69522005, "operatingMargins": -7.43291, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-20"}]